Osso VR announced today that it launched Osso Health, a medical training app for use on the Apple Vision Pro system. The offering leverages the power of Apple Vision Pro to blend digital content with the physical world. Osso VR aims to bring the operating experience to live through detailed, clinically accurate workflows of common […]
Apple
Samsung could battle Apple over non-invasive glucose monitors
Bloomberg reports that Samsung has eyes on developing non-invasive glucose monitoring technology, potentially pitting it against Apple. The report says the electronics company wants to develop continuous blood pressure checking along with glucose monitoring. It comes as part of an effort to incorporate health features in Samsung devices, like its Galaxy Ring, Bloomberg says. Hon Pak, […]
Court grants AliveCor stay in patent battle with Apple as PTAB investigation goes on
The United States District Court of the Northern District of California allowed AliveCor a stay in legal proceedings against tech giant Apple. AliveCor and Apple have a longstanding legal battle ongoing over the use of ECG technology for detecting AFib. Last week, the U.S. Patent Trial and Appeal Board’s (PTAB) agreed to institute three of […]
Court denies Apple’s watch ban appeal in Masimo patent spat
Bloomberg reports that the U.S. Court of Appeals for the Federal Circuit declined to grant a longer pause on the Apple Watch import ban as a result of patent litigation with Masimo . Shares of MASI were up 2.1% to $122.57 apiece just before the market closed today on the back of the news. The […]
Apple reportedly pulling pulse oximetry from watches if Masimo case appeal fails
Federal customs officials have reportedly approved Apple’s workaround to continue importing Series 9 and Ultra 2 watches if it fails in its appeal of an import ban in its patent dispute with Masimo. The consumer tech giant has told U.S. Customs and Border Protection that redesigned watches “definitively do not contain pulse oximetry functionality,” according […]
PTAB to review Apple’s ECG patents amid legal battle with AliveCor
The U.S. Patent Trial and Appeal Board (PTAB) will review two Apple-owned electrocardiogram technology patents in an infringement suit as AliveCor looks to overcome a setback with the board in December 2023. A panel of administrative patent judges granted AliveCor’s bid for a review, citing a “reasonable likelihood” that AliveCor would successfully show the unpatentability […]
The 10 biggest diabetes tech stories from 2023
It was another banner year for diabetes technology, with regulatory approvals, product launches and M&A all playing their part. Diabetes technology’s impressive 12 months marked a major trend across medtech as a whole, too. In 2022, the diabetes space saw plenty of progress from some of its biggest names and this past year proved no different. […]
Apple Watch ban goes into effect after Masimo patent battle, presidential review
President Joe Biden’s administration declined to veto an import ban on Apple Watches after the government ruled in favor of Masimo in a patent spat. The long-running battle between companies came to a head last week when Apple paused sales of two models of its smartwatch. This spat centers around light-based pulse oximetry technology used […]
Apple reportedly stops U.S. sales of certain smartwatches amid Masimo patent spat
Apple reportedly paused sales of two models of its smartwatches in the U.S. as it looks to resolve a patent dispute with Masimo . Apple confirmed the decision in a statement to 9to5Mac. The patent spat goes back as far as January 2020, centering around light-based pulse oximetry technology used by the watches. Masimo develops […]
ITC rules in favor of Masimo in Apple Watch patent spat, stock rises
Masimo announced that the U.S. International Trade Commission (ITC) ruled in its favor in an ongoing patent battle with tech giant Apple. Shares of MASI ticked up more than 5% at $85.26 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. […]
Masimo beats the Street in Q1 ahead of proxy fight; CEO discusses Apple mistrial
Masimo reported Street-beating first-quarter results and maintained its full-year 2023 guidance ahead of a proxy battle at the annual meeting of shareholders. Investors reacted by sending MASI shares up 1% to $186.50 apiece in after-hours trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down slightly. The […]